Literature DB >> 23394409

Patient's willingness to opt for external cephalic version.

Floortje Vlemmix1, Marjon Kuitert, Joke Bais, Brent Opmeer, Joris van der Post, Ben Willem Mol, Marjolein Kok.   

Abstract

OBJECTIVE: External cephalic version (ECV) is a relatively simple and safe maneuver that reduces the cesarean section (CS) rate for breech presentation. There is professional consensus that ECV should be offered to all women, but only up to 70% of patients opt for this treatment. To improve counseling, we investigated the value patients place on various aspects of ECV.
METHODS: We studied patient preferences by means of a vignette study. Varying levels of treatment characteristics were investigated in 16 scenarios, all including the "opt out" alternative of an elective CS. The probability that women preferred ECV was estimated using a logistic regression approach.
RESULTS: Forty seven women participated in the study. Pain was the most important factor negatively influencing the willingness to opt for ECV (OR 0.11 (95% confidence interval (CI) 0.05-0.23) for a pain score of 8-10 compared to 1-2 on a visual analog scale of 0-10). Higher success rates of vaginal delivery after successful ECV increased women's willingness (OR 3.42 (95% CI 2.04-5.74), if chance of vaginal delivery after successful ECV increased from 24% to 52%). The risk of an emergency CS during ECV did not influence the willingness to opt for ECV (OR 0.83 (95% CI 0.59-1.18) of chance increased from 0% to 1%).
CONCLUSIONS: We conclude that expected pain during treatment and the success rate are the most important factors influencing the willingness to undergo ECV. Taking this information into account when counseling for ECV and reassuring women that unbearable pain is always a reason to stop ECV, and that the vast majority of women reported that the experienced pain is bearable, might improve the uptake of ECV and decrease the number of CS due to breech presentation.

Entities:  

Mesh:

Year:  2013        PMID: 23394409     DOI: 10.3109/0167482X.2012.760540

Source DB:  PubMed          Journal:  J Psychosom Obstet Gynaecol        ISSN: 0167-482X            Impact factor:   2.949


  7 in total

Review 1.  Risk as an attribute in discrete choice experiments: a systematic review of the literature.

Authors:  Mark Harrison; Dan Rigby; Caroline Vass; Terry Flynn; Jordan Louviere; Katherine Payne
Journal:  Patient       Date:  2014       Impact factor: 3.883

2.  Coming out ahead: the cost effectiveness of external cephalic version using spinal anesthesia.

Authors:  James A O'Brien; Eli Y Adashi
Journal:  Isr J Health Policy Res       Date:  2014-02-24

3.  Reducing the cesarean delivery rates for breech presentations: administration of spinal anesthesia facilitates manipulation to cephalic presentation, but is it cost saving?

Authors:  Carolyn F Weiniger; Paul S Spencer; Yuval Weiss; Gary Ginsberg; Yossef Ezra
Journal:  Isr J Health Policy Res       Date:  2014-02-24

4.  Atosiban versus fenoterol as a uterine relaxant for external cephalic version: randomised controlled trial.

Authors:  Joost Velzel; Floortje Vlemmix; Brent C Opmeer; Jan F M Molkenboer; Corine J Verhoeven; Mariëlle G van Pampus; Dimitri N M Papatsonis; Joke M J Bais; Karlijn C Vollebregt; Liesbeth van der Esch; Joris A M Van der Post; Ben Willem Mol; Marjolein Kok
Journal:  BMJ       Date:  2017-01-26

5.  A prospective study using an individualized nomogram to predict the success rate of external cephalic version.

Authors:  Jing Lin; Wei Liu; Wei Gu; Ye Zhou
Journal:  Sci Rep       Date:  2022-07-12       Impact factor: 4.996

6.  This baby is not for turning: Women's experiences of attempted external cephalic version.

Authors:  N P Watts; K Petrovska; A Bisits; C Catling; C S E Homer
Journal:  BMC Pregnancy Childbirth       Date:  2016-08-26       Impact factor: 3.007

7.  A randomised controlled trial to assess the feasibility of utilising virtual reality to facilitate analgesia during external cephalic version.

Authors:  Vinayak Smith; Ritesh Rikain Warty; Ravi Kashyap; Peter Neil; Carol Adriaans; Amrish Nair; Sathya Krishnan; Fabricio Da Silva Costa; Beverley Vollenhoven; Euan M Wallace
Journal:  Sci Rep       Date:  2020-02-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.